InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,725.27
(
0.44%
)
US TECH 100
19,385.20
(
0.63%
)
Dow Jones
42,119.90
(
0.26%
)
Brent Oil
78.44
(
0.82%
)
Bitcoin
61,776.35
(
1.69%
)
Post# of 253275
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120528
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: floblu14 post# 115954

Sunday, 03/06/2011 6:57:16 PM

Sunday, March 06, 2011 6:57:16 PM

Post# of 253275

…is it correct to say that TEVA could possibly get an injunction which would prevent Sandoz/MNTA launching at risk for generic copaxone?

No, we cannot say that. Teva might be able to get a preliminary injunction to block the launch of generic Copaxone; however, the likelihood of Teva’s getting a PI will be diminished if the Judge believes Teva is unlikely to prevail in the Copaxone trial.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up